文献速递血液淋巴病理

MarrowQuant 2.0:辅助实验与临床血液学骨髓评估的数字病理工作流

MarrowQuant 2.0: A Digital Pathology Workflow Assisting Bone Marrow Evaluation in Experimental and Clinical Hematology.
PubMed 文献 · Mod Pathol · 2023-01-10

本研究开发并验证了集成于QuPath的MarrowQuant 2.0数字病理工作流,用于骨髓活检的5个互斥分区分割和细胞度评估。在250例标本中,算法平均掩膜准确率86%,与4名血液病理学家的视觉评分高度相关(R²=0.92-0.98,ICC=0.98)。前瞻性临床常规诊断标本(n=42)中性能相似(R²=0.86),支持其作为可靠的骨髓细胞度评估工具。

要点

  • MarrowQuant 2.0可自动分割骨髓的骨、造血、脂肪、间质/微血管和其他5个分区。
  • 算法与血液病理学家细胞度评分高度相关(R²=0.92-0.98,ICC=0.98)。
  • 在临床常规诊断标本中验证性能相似(R²=0.86,n=42)。

核心结论

  • MarrowQuant 2.0是可靠的骨髓细胞度评估工具,可用于探索骨髓间质成分相关生物标志物。

研究设计与样本

  • 开发并验证集成于QuPath的数字病理工作流,使用250例对照、急性髓系白血病或骨髓增生异常综合征患者的骨标本。
  • 将算法细胞度估计与4名血液病理学家的视觉评分进行一致性比较。
  • 在前瞻性收集的42例临床常规诊断标本中测试性能。

主要发现

  • 算法平均掩膜准确率为86%,骨、造血和脂肪区域分别达99%、92%和98%。
  • MarrowQuant 2.0细胞度评分与血液病理学家估计高度相关(R²=0.92-0.98,ICC=0.98;观察者间ICC=0.96)。
  • 骨髓分区分割定量证实了造血与脂肪分区的互补性。
  • 前瞻性临床标本中性能相似(R²=0.86,n=42),但需特别考虑间质扩张标本的细胞度公式选择。

临床怎么用

  • 可用于骨髓活检的定量细胞度评估,辅助血液病理学家视觉评分。
  • 有望作为临床研究工具探索骨髓间质成分相关的新生物标志物。

局限性

  • 在间质扩张标本中需特别考虑细胞度公式的选择。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Bone marrow (BM) cellularity assessment is a crucial step in the evaluation of BM trephine biopsies for hematologic and nonhematologic disorders. Clinical assessment is based on a semiquantitative visual estimation of the hematopoietic and adipocytic components by hematopathologists, which does not provide quantitative information on other stromal compartments. In this study, we developed and validated MarrowQuant 2.0, an efficient, user-friendly digital hematopathology workflow integrated within QuPath software, which serves as BM quantifier for 5 mutually exclusive compartments (bone, hematopoietic, adipocytic, and interstitial/microvasculature areas and other) and derives the cellularity of human BM trephine biopsies. Instance segmentation of individual adipocytes is realized through the adaptation of the machine-learning-based algorithm StarDist. We calculated BM compartments and adipocyte size distributions of hematoxylin and eosin images obtained from 250 bone specimens, from control subjects and patients with acute myeloid leukemia or myelodysplastic syndrome, at diagnosis and follow-up, and measured the agreement of cellularity estimates by MarrowQuant 2.0 against visual scores from 4 hematopathologists. The algorithm was capable of robust BM compartment segmentation with an average mask accuracy of 86%, maximal for bone (99%), hematopoietic (92%), and adipocyte (98%) areas. MarrowQuant 2.0 cellularity score and hematopathologist estimations were highly correlated (R2 = 0.92-0.98, intraclass correlation coefficient [ICC] = 0.98; interobserver ICC = 0.96). BM compartment segmentation quantitatively confirmed the reciprocity of the hematopoietic and adipocytic compartments. MarrowQuant 2.0 performance was additionally tested for cellularity assessment of specimens prospectively collected from clinical routine diagnosis. After special consideration for the choice of the cellularity equation in specimens with expanded stroma, performance was similar in this setting (R2 = 0.86, n = 42). Thus, we conclude that these validation experiments establish MarrowQuant 2.0 as a reliable tool for BM cellularity assessment. We expect this workflow will serve as a clinical research tool to explore novel biomarkers related to BM stromal components and may contribute to further validation of future digitalized diagnostic hematopathology workstreams.

来源:Mod Pathol,查看原文。版权归原作者所有。

引用

  1. Sarkis R, Burri O, Royer-Chardon C, et al. MarrowQuant 2.0: A Digital Pathology Workflow Assisting Bone Marrow Evaluation in Experimental and Clinical Hematology. Mod Pathol. 2023. PMID: 36788087. doi:10.1016/j.modpat.2022.100088

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。